HeartLung Receives FDA “Breakthrough” Designation and Marketing Authorization for the First AI to Enable Opportunistic Detection of Hidden Heart Disease in Millions of CT Scans
Knowledge Center
HeartLung's distinguished advisor, Dr. Claudia Henschke, who pioneered lung cancer screening, wins the RSNA 2024 Scientific Excellence Award 🏆⚕️
HeartLung Technologies to Present Four Scientific Research Studies on AI-CAC™, AutoBMD™, and AI-CVD™ at the 2024 Radiological Society of North America (RSNA 2024)
AI-enabled Cardiac Chambers Volumetry in Non-contrast Coronary Artery Calcium CT Scans vs. Contrast-Enhanced Coronary CT Angiography Scans in the Same Patients
AI-enabled Cardiac Chambers Volumetry in Coronary Artery Calcium (CAC) Scans (AI-CAC) Significantly Improves on Agatston CAC Score for Predicting All Cardiovascular Events:
Automated Left Ventricular Volumetry using Artificial Intelligence in Coronary Calcium Scans (AI-CAC) Predicts Heart Failure Comparably to Cardiac MRI and Outperforms NT-proBNP:
Coronary Artery Calcium Scans Powered by Artificial Intelligence (AI-CAC) Predicts Atrial Fibrillation and Stroke Comparably to Cardiac Magnetic Resonance Imaging:
AI-enabled Cardiac Chambers Volumetry in Non-Contrast Cardiac CT scans Detects HFrEF vs. HFpEF
AI-enabled automated bone mineral density measurement in coronary artery calcium scans (AutoBMD) is associated with high coronary artery calcium score independently of conventional risk factors: